BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241028
DTEND;VALUE=DATE:20241031
DTSTAMP:20240608T024959Z
CREATED:20240226T195121Z
LAST-MODIFIED:20240608T024959Z
UID:5367-1730073600-1730332799@thebiocalendar.com
SUMMARY:BioFuture
DESCRIPTION:New York City | October 28-30\, 2024\nVirtual | November 5-7\, 2024 \nInnovators & Investors Come Together to Shape the Future of Healthcare \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBioFuture is where relentless therapeutic pioneers\, innovators\, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid\, unfiltered discussions. At this year’s summit\, we’ll explore the exciting convergence between rapidly evolving fields including biopharma\, digital medicine\, big data\, AI\, healthcare systems\, payors\, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. \n\nThis year’s event will be a melting pot of cross-industry ideas and insights that fuse the swiftly developing fields of biopharma\, digital medicine\, big data\, artificial intelligence\, healthcare systems\, insurance providers\, and beyond.
URL:https://thebiocalendar.com/event/biofuture-2/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/06/ryhm.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241029
DTEND;VALUE=DATE:20241031
DTSTAMP:20240827T194721Z
CREATED:20240827T194721Z
LAST-MODIFIED:20240827T194721Z
UID:6251-1730160000-1730332799@thebiocalendar.com
SUMMARY:BIO on the BAYOU
DESCRIPTION:BIO on the BAYOU presents University Research the way YOU want it\, as the signature event showcases academic science & biotech from the entire Gulf South region. Join senior executives and top decision-makers from the corporate\, investor\, foundation\, government\, and academic sectors as we work together at the business conference to advance cutting-edge research from the bench to the bedside.   \nThis 2024 program – which will be held in person in New Orleans\, Louisiana – will continue to evolve as it features expert-led panels\, private meeting capabilities powered by partneringONE\, networking opportunities\, and most importantly business-style scientific presentations straight from researchers at leading Gulf South universities including Tulane University\, Auburn University\, LSU Health New Orleans\, The University of Mississippi\, Xavier University of Louisiana\, Jackson State University\, LSU Health Shreveport\, The University of Kentucky\, The University of Louisville\, Mississippi State\, Pennington Biomedical Research Center\, The Puerto Rico Science\, Technology & Research Trust. the University of Southern Mississippi and the University of Tennessee.  \nMake your Travel Plans and Get Ready to join us in New Orleans in October\, 2024… \n…And Stay for Halloween\, New Orleans Style!  
URL:https://thebiocalendar.com/event/bio-on-the-bayou/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241030T110000
DTEND;TZID=UTC:20241030T150000
DTSTAMP:20240918T012341Z
CREATED:20240918T003448Z
LAST-MODIFIED:20240918T012341Z
UID:6388-1730286000-1730300400@thebiocalendar.com
SUMMARY:The State of AI in Drug Discovery 2024
DESCRIPTION:Artificial Intelligence (AI) and machine learning are transforming the worlds of biotechnology and pharma\, particularly in the arena of drug discovery. Leveraging the rise of large datasets and massive compute power\, AI appears poised to expedite and\, in some cases\, reimagine the design of novel and more effective therapeutics\, from cell and gene therapy\, oncology\, neuroscience\, and more. \nIn GEN’s inaugural virtual summit\, The State of AI in Drug Discovery\, we proudly host an outstanding group of thought-leaders\, researchers and AI entrepreneurs across industry and academia to showcase the latest advances\, challenges and concerns regarding the deployment of AI in biotech\, with particular emphasis on disrupting the drug discovery process. This exciting event brings together founders and executives from many of the most exciting companies powering the AI revolution\, including Recursion\, 1910 Genetics\, Profluent\, Terray Therapeutics\, Generate:Biomedicines\, and more!
URL:https://thebiocalendar.com/event/the-state-of-ai-in-drug-discovery-2024/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241030T130000
DTEND;TZID=UTC:20241030T140000
DTSTAMP:20240827T200535Z
CREATED:20240827T200535Z
LAST-MODIFIED:20240827T200535Z
UID:6255-1730293200-1730296800@thebiocalendar.com
SUMMARY:Ansu Satpathy\, Stanford: “High-Throughput Genomics and Cancer Therapeutics”
DESCRIPTION:Dr. Ansuman Satpathy\, M.D.\, Ph.D.\, is a physician-scientist and Associate Professor of Pathology and Immunology at Stanford University. He is the director of the Stanford Center for Immunotherapy Design\, co-director of the Parker Institute for Cancer Immunotherapy\, and co-director of the Immunotherapy Program in the Stanford Cancer Institute. Ansu’s research combines expertise in immunology\, high-throughput genomics\, and computation to discover principles of the immune system in health and disease and to translate these discoveries into novel clinical therapeutics. He is a co-founder of Immunai\, Cartography Biosciences\, Santa Ana Bio\, and Prox Biosciences\, and a venture partner at Wing Venture Capital.
URL:https://thebiocalendar.com/event/ansu-satpathy-stanford-high-throughput-genomics-and-cancer-therapeutics/
END:VEVENT
END:VCALENDAR